| inborn errors of amino acid metabolismMetabolic | 4 | 0 | 0% | |
| prostate cancerOncology | 4 | 0 | 0% | |
| narcolepsyNeurology | 3 | 0 | 0% | |
| systemic juvenile idiopathic arthritisRheumatology | 3 | 0 | 0% | |
| urea cycle disordersMetabolic | 3 | 0 | 0% | |
| spasticity post-strokeNeurology | 3 | 0 | 0% | |
| iron deficiency anaemiaOther | 3 | 0 | 0% | |
| pyruvate dehydrogenase deficiencyMetabolic | 3 | 0 | 0% | |
| nicotine dependenceAddiction medicine | 3 | 0 | 0% | |
| neuropathic painPain | 3 | 0 | 0% | |
| chronic renal failureMetabolic | 3 | 0 | 0% | |
| dry eye syndromeOphthalmology | 11 | 1 | 9% | |
| phenylketonuriaMetabolic | 48 | 5 | 10% | Disorders Association, PKU Association of NSW |
| HIV infectionInfectious disease | 6 | 1 | 17% | |
| androgen deficiencyEndocrinology | 5 | 1 | 20% | Western Sydney Transgender Support Group, Association for Transgender Health |
| rheumatoid arthritisRheumatology | 19 | 4 | 21% | Creaky Joints Australia |
| HIV-1 infectionInfectious disease | 13 | 3 | 23% | National Association for People Living, National Aboriginal Community Controlled Health Organisation |
| cryopyrin-associated periodic syndromesRare disease | 4 | 1 | 25% | Autoinflammatory Alliance |
| breast cancerOncology | 4 | 1 | 25% | Breast Cancer Network Australia |
| Clostridium difficile infection recurrenceInfectious disease | 4 | 1 | 25% | |
| anovulatory infertilityWomen's health | 4 | 1 | 25% | |
| cancer breakthrough painPain | 4 | 1 | 25% | |
| infertility (assisted reproductive technology)Women's health | 4 | 1 | 25% | ACCESS Australia, National Infertility Network |
| type 1 diabetesEndocrinology | 4 | 1 | 25% | DANII Foundation, Diabetes Alliance |
| central precocious pubertyEndocrinology | 4 | 1 | 25% | |
| chemotherapy-induced neutropeniaOncology | 4 | 1 | 25% | |
| hyperphosphataemia in chronic kidney diseaseEndocrinology | 4 | 1 | 25% | |
| non-radiographic axial spondyloarthritisRheumatology | 11 | 3 | 27% | CreakyJoints Australia, Translational Research Institute |
| opioid dependencePain | 6 | 2 | 33% | |
| herpes simplex keratitisOphthalmology | 3 | 1 | 33% | |
| open-angle glaucoma and ocular hypertensionOphthalmology | 3 | 1 | 33% | |
| venous thromboembolismCardiovascular | 3 | 1 | 33% | |
| opioid use disorderPain | 3 | 1 | 33% | Better Access Australia |
| infertilityWomen's health | 3 | 1 | 33% | Access Australia |
| pancreatic cancerOncology | 3 | 1 | 33% | Medical Oncology Group, Pancare Foundation |
| acromegalyEndocrinology | 3 | 1 | 33% | Endocrine Society of Australia, Australian Pituitary Foundation |
| uterine fibroidsWomen's health | 3 | 1 | 33% | |
| chronic graft versus host diseaseHaematology | 3 | 1 | 33% | Leukaemia Foundation, Rare Cancers Australia |
| acute coronary syndromeCardiovascular | 3 | 1 | 33% | National Aboriginal Community Controlled Health Organisation |
| preterm birth preventionWomen's health | 3 | 1 | 33% | Preterm Infants Parents Association, Australian Preterm Birth Alliance |
| type 2 diabetesEndocrinology | 59 | 21 | 36% | Diabetes Australia, National Aboriginal Community Controlled Health Organisation |
| chemotherapy-induced nausea and vomitingOncology | 10 | 4 | 40% | Society of Hospital Pharmacists of Australia |
| growth hormone deficiencyEndocrinology | 10 | 4 | 40% | Australian Pituitary Foundation, Endocrine Society of Australia |
| hypercholesterolaemiaCardiovascular | 5 | 2 | 40% | FH Family Support Group, Heart Support Australia |
| heart failure with reduced ejection fractionCardiovascular | 5 | 2 | 40% | Diabetes Australia, National Aboriginal Community Controlled Health Organisation |
| invasive meningococcal diseaseVaccines | 5 | 2 | 40% | Meningitis Centre Australia |
| basal cell carcinomaDermatology | 5 | 2 | 40% | Rare Cancers Australia |
| Parkinson's diseaseNeurology | 17 | 7 | 41% | Hospital Research Foundation Group |
| ankylosing spondylitisRheumatology | 7 | 3 | 43% | CreakyJoints Australia, Musculoskeletal Australia |
| influenzaVaccines | 7 | 3 | 43% | Diabetes Australia, Lung Foundation Australia |
| Wilson diseaseHepatology | 7 | 3 | 43% | |
| COPDRespiratory | 35 | 16 | 46% | Lung Foundation Australia, Lung Foundation |
| osteoporosisEndocrinology | 15 | 7 | 47% | Healthy Bones Australia, Endocrine Society of Australia |
| plaque psoriasisRheumatology | 50 | 24 | 48% | Psoriasis Australia, Colitis Australia |
| schizophreniaMental health | 14 | 7 | 50% | |
| juvenile idiopathic arthritisRheumatology | 12 | 6 | 50% | Colitis Australia, Australian Rheumatology Association |
| HCCOncology | 10 | 5 | 50% | Rare Cancers Australia, Medical Oncology Group |
| seasonal influenzaVaccines | 8 | 4 | 50% | Lung Foundation Australia, Australian Immunisation Register |
| paroxysmal nocturnal haemoglobinuriaHaematology | 6 | 3 | 50% | PNH Support Association of Australia |
| pneumococcal disease preventionVaccines | 4 | 2 | 50% | Lung Foundation Australia |
| age-related macular degenerationOphthalmology | 4 | 2 | 50% | Macular Disease Foundation Australia |
| non-familial hypercholesterolaemia with ASCVDCardiovascular | 4 | 2 | 50% | |
| cows' milk protein allergy and enteropathyMetabolic | 4 | 2 | 50% | Australasian Society of Clinical Immunology and Allergy, National Allergy Council |
| Lennox-Gastaut syndromeNeurology | 4 | 2 | 50% | Epilepsy Action Australia, Epilepsy Foundation |
| Dravet syndromeNeurology | 4 | 2 | 50% | Epilepsy Society of Australia, Epilepsy Society |
| chronic iron overloadHaematology | 4 | 2 | 50% | Thalassaemia Society of NSW, Leukaemia Foundation |
| atypical haemolytic uraemic syndromeRare disease | 4 | 2 | 50% | |
| influenza preventionVaccines | 4 | 2 | 50% | Lung Foundation Australia |
| GEP-NETOncology | 4 | 2 | 50% | NeuroEndocrine Cancer Australia |
| chronic painPain | 4 | 2 | 50% | Pharmaceutical Society of Australia, Australian Pain Society |
| chronic spontaneous urticariaImmunology | 4 | 2 | 50% | National Allergy Council, Anaphylaxis Australia |
| psoriatic arthritisRheumatology | 19 | 10 | 53% | CreakyJoints Australia, Creaky Joints Australia |
| chronic hepatitis CHepatology | 20 | 11 | 55% | Gastroenterological Society of Australia, Hepatitis Australia |
| cutaneous T-cell lymphomaOncology | 9 | 5 | 56% | Leukaemia Foundation, Rare Cancers Australia |
| prostate cancer (mCRPC)Oncology | 21 | 12 | 57% | Medical Oncology Group, Prostate Cancer Foundation |
| anaphylaxisImmunology | 7 | 4 | 57% | Anaphylaxis Australia, Australasian Society of Clinical Immunology and Allergy |
| CMLHaematology | 7 | 4 | 57% | Leukaemia Foundation, Leukemia Foundation |
| ALLHaematology | 12 | 7 | 58% | Leukaemia Foundation, Rare Cancers Australia |
| severe eosinophilic asthmaRespiratory | 8 | 5 | 63% | Asthma Australia, National Asthma Council Australia |
| pulmonary arterial hypertensionCardiovascular | 11 | 7 | 64% | Lung Foundation Australia, Pulmonary Hypertension Australia |
| gastric cancerOncology | 11 | 7 | 64% | Medical Oncology Group, Rare Cancers Australia |
| FLOncology | 11 | 7 | 64% | Lymphoma Australia, Leukaemia Foundation |
| contraceptionWomen's health | 6 | 4 | 67% | National Aboriginal Community Controlled Health Organisation, Research Institute |
| familial hypercholesterolaemiaCardiovascular | 6 | 4 | 67% | Familial Hypercholesterolaemia Australasia Network, FH Family Support Group |
| myelofibrosisHaematology | 6 | 4 | 67% | Alliance Australia, Leukaemia Foundation |
| post-herpetic neuralgiaPain | 6 | 4 | 67% | Pain Australia, Gastroenterological Society of Australia |
| Fabry diseaseRare disease | 6 | 4 | 67% | Fabry Australia, Rare Voices Australia |
| classical Hodgkin's lymphomaHaematology | 3 | 2 | 67% | Leukaemia Foundation |
| differentiated thyroid carcinomaOncology | 3 | 2 | 67% | Australian Thyroid Foundation |
| prostate cancer (nmHSPC)Oncology | 3 | 2 | 67% | Rare Cancers Australia, Medical Oncology Group Australia |
| hereditary angioedema (HAE)Rare disease | 3 | 2 | 67% | |
| idiopathic generalised epilepsyNeurology | 3 | 2 | 67% | |
| PTCLOncology | 3 | 2 | 67% | Snowdome Foundation, Lymphoma Australia |
| HER2+ breast cancerOncology | 19 | 13 | 68% | Medical Oncology Group, Breast Cancer Network Australia |
| CRCOncology | 7 | 5 | 71% | Medical Oncology Group, Bowel Cancer Australia |
| amyotrophic lateral sclerosisNeurology | 7 | 5 | 71% | Motor Neurone Disease Australia, MND Australia |
| ulcerative colitisRheumatology | 29 | 21 | 72% | Colitis Australia, Australian Inflammatory Bowel Disease Association |
| asthmaRespiratory | 29 | 21 | 72% | Asthma Australia, Lung Foundation |
| hidradenitis suppurativaRheumatology | 11 | 8 | 73% | Colitis Australia, Hidradenitis Suppurativa Australia |
| UCOncology | 11 | 8 | 73% | Medical Oncology Group, BEAT Bladder Cancer Australia |
| heart failureCardiovascular | 11 | 8 | 73% | Diabetes Australia, National Aboriginal Community Controlled Health Organisation |
| melanomaOncology | 37 | 27 | 73% | Melanoma Patients Australia, Medical Oncology Group |
| CLLHaematology | 27 | 20 | 74% | Lymphoma Australia, Leukaemia Foundation |
| multiple sclerosisNeurology | 32 | 24 | 75% | MS Australia, MS Research Australia |
| AMLHaematology | 12 | 9 | 75% | Leukaemia Foundation, Rare Cancers Australia |
| mCRCOncology | 8 | 6 | 75% | Bowel Cancer Australia, Medical Oncology Group |
| primary biliary cholangitisHepatology | 8 | 6 | 75% | Liver Foundation, PBC Foundation |
| relapsing-remitting multiple sclerosisNeurology | 4 | 3 | 75% | MS Research Australia, MS Australia |
| short bowel syndromeGastroenterology | 4 | 3 | 75% | |
| urea cycle disorderMetabolic | 4 | 3 | 75% | Metabolic Dietary Disorders Association |
| intractable partial onset epilepsyNeurology | 4 | 3 | 75% | Epilepsy Action Australia, Epilepsy Foundation |
| macular oedema secondary to retinal vein occlusionOphthalmology | 4 | 3 | 75% | Macular Disease Foundation Australia |
| type 1 and type 2 diabetesEndocrinology | 4 | 3 | 75% | JDRF Australia, Australian Diabetes Society |
| oesophageal squamous cell carcinomaOncology | 4 | 3 | 75% | Medical Oncology Group, Rare Cancers Australia |
| peripheral T-cell lymphomaHaematology | 4 | 3 | 75% | Rare Cancer Australia, Rare Cancers Australia |
| autosomal dominant polycystic kidney diseaseRare disease | 4 | 3 | 75% | Kidney Health Australia, PKD Foundation Australia |
| diabetic macular oedemaOphthalmology | 9 | 7 | 78% | Macular Disease Foundation Australia, Macular Disease Foundation |
| RCCOncology | 20 | 16 | 80% | Medical Oncology Group, Rare Cancers Australia |
| hereditary angioedemaRare disease | 5 | 4 | 80% | HAE Australia |
| ADHDNeurology | 5 | 4 | 80% | ADHD Australia, ADHD Foundation |
| COVID-19Infectious disease | 5 | 4 | 80% | Lung Foundation Australia, Kirby Institute |
| NSCLCOncology | 55 | 45 | 82% | Medical Oncology Group, Lung Foundation Australia |
| HR+/HER2- breast cancerOncology | 22 | 18 | 82% | Medical Oncology Group, Breast Cancer Network Australia |
| MMOncology | 52 | 43 | 83% | Myeloma Australia, Leukaemia Foundation |
| cystic fibrosisRare disease | 30 | 25 | 83% | Cystic Fibrosis Australia, Cystic Fibrosis Specialist Interest Group |
| Crohn's diseaseRheumatology | 24 | 20 | 83% | Colitis Australia, Israel Medical Association |
| prostate cancer (mHSPC)Oncology | 6 | 5 | 83% | Medical Oncology Group, Prostate Cancer Foundation |
| chronic hepatitis C virus infectionHepatology | 6 | 5 | 83% | Hepatitis Australia, Haemophilia Foundation Australia |
| oesophageal cancerOncology | 6 | 5 | 83% | Pancare Foundation, Medical Oncology Group |
| ALK+ NSCLCOncology | 7 | 6 | 86% | Rare Cancers Australia, Medical Oncology Group |
| prostate cancer (nmCRPC)Oncology | 7 | 6 | 86% | Medical Oncology Group, Prostate Cancer Foundation |
| ovarian cancerOncology | 15 | 13 | 87% | Medical Oncology Group, Ovarian Cancer Australia |
| cervical cancerOncology | 8 | 7 | 88% | Medical Oncology Group, Rare Cancers Australia |
| chronic kidney diseaseEndocrinology | 8 | 7 | 88% | Kidney Health Australia, Diabetes Australia |
| idiopathic pulmonary fibrosisRespiratory | 8 | 7 | 88% | Lung Foundation Australia, Lung Foundation |
| chronic migraineNeurology | 12 | 11 | 92% | Migraine Australia, Headache Australia |
| spinal muscular atrophyNeurology | 14 | 13 | 93% | Spinal Muscular Atrophy Australia, SMA Australia |
| atopic dermatitisDermatology | 20 | 19 | 95% | Eczema Support Australia, Anaphylaxis Australia |
| HNSCCOncology | 9 | 9 | 100% | Rare Cancers Australia, Medical Oncology Group |
| MCLHaematology | 7 | 7 | 100% | Leukaemia Foundation, Lymphoma Australia |
| TNBCOncology | 7 | 7 | 100% | Medical Oncology Group, Breast Cancer Network Australia |
| endometrial cancerOncology | 7 | 7 | 100% | Medical Oncology Group, Rare Cancers Australia |
| generalised myasthenia gravisNeurology | 7 | 7 | 100% | Myasthenia Alliance Australia, Myasthenia Gravis Association of Queensland |
| DLBCLHaematology | 7 | 7 | 100% | Rare Cancers Australia, Leukaemia Foundation |
| CLL/SLLHaematology | 6 | 6 | 100% | Rare Cancers Australia, Leukaemia Foundation |
| pneumococcal diseaseVaccines | 5 | 5 | 100% | Lung Foundation Australia, Immunisation Foundation |
| systemic lupus erythematosusRheumatology | 5 | 5 | 100% | National Aboriginal Community Controlled Health Organisation, Australian Rheumatology Association |
| SCLCOncology | 5 | 5 | 100% | Medical Oncology Group, Lung Foundation Australia |
| RSV lower respiratory tract diseaseVaccines | 5 | 5 | 100% | Asthma Australia, Lung Foundation Australia |
| Hodgkin lymphomaHaematology | 4 | 4 | 100% | Leukaemia Foundation, Lymphoma Australia |
| treatment-resistant depressionMental health | 4 | 4 | 100% | Lived Experience Australia, Samy Medical Group |
| eosinophilic oesophagitisGastroenterology | 3 | 3 | 100% | Australasian Society of Clinical Immunology and Allergy, Anaphylaxis Australia |
| granulomatosis with polyangiitis and microscopic polyangiitisRare disease | 3 | 3 | 100% | Australasian Society of Clinical Immunology and Allergy, Australian Rheumatology Association |
| Merkel cell carcinomaOncology | 3 | 3 | 100% | Rare Cancers Australia, Medical Oncology Group |
| chronic hepatitis DHepatology | 3 | 3 | 100% | Hepatitis Australia, Liver Foundation |
| X-linked hypophosphataemiaRare disease | 3 | 3 | 100% | Australasian Paediatric Endocrine Group, XLH Australia |
| cutaneous squamous cell carcinomaOncology | 3 | 3 | 100% | Medical Oncology Group, Skin Cancer Advocacy Network |
| ROS1+ NSCLCOncology | 3 | 3 | 100% | Medical Oncology Group, Lung Foundation Australia |
| endometriosisWomen's health | 3 | 3 | 100% | National Aboriginal Community Controlled Health Organisation, Pelvic Pain Foundation |
| biliary tract cancerOncology | 3 | 3 | 100% | Medical Oncology Group, Cholangiocarcinoma Foundation Australia |
| neuromyelitis optica spectrum disorderNeurology | 3 | 3 | 100% | MS Australia, MS Research Australia |
| cholangiocarcinomaOncology | 3 | 3 | 100% | Pancare Foundation, Liver Foundation |
| pancreatic adenocarcinomaOncology | 3 | 3 | 100% | Australian Pancreatic Cancer Foundation, Rare Cancers Australia |
| obstructive hypertrophic cardiomyopathyCardiovascular | 3 | 3 | 100% | Cardiomyopathy Association of Australia |
| chronic rhinosinusitis with nasal polypsImmunology | 3 | 3 | 100% | Australasian Society of Clinical Immunology and Allergy, Anaphylaxis Australia |
| generalised convulsive status epilepticusNeurology | 3 | 3 | 100% | Epilepsy Australia, Epilepsy Action Australia |
| UC (urothelial)Oncology | 3 | 3 | 100% | Medical Oncology Group, BEAT Bladder Cancer Australia |
| mesotheliomaOncology | 3 | 3 | 100% | Lung Foundation Australia, Asbestos Victims Association |
| severe allergic asthmaRespiratory | 3 | 3 | 100% | |
| chronic thromboembolic pulmonary hypertensionRespiratory | 3 | 3 | 100% | Pulmonary Hypertension Association Australia |
| severe osteoporosisEndocrinology | 3 | 3 | 100% | Healthy Bones Australia, Osteoporosis Australia |